It's a New Day in Public Health.
The Florida Department of Health works to protect, promote, and improve the health of all people in Florida through integrated state, county, and community efforts.
Left navigation requires javascript to be enabled in your browser.
Clinical Resources
HIV/AIDS
- 850-245-4422
- DiseaseControl@flhealth.gov
-
Mailing Address
HIV/AIDS Section
4052 Bald Cypress Way
Tallahassee, FL 32399
- General Information
- Long-Acting Injectable Resources
- nPEP, PrEP and Test & Treat Guidance
- Medication Formularies
- FAQ and Provider Resources
- HIV Phone Consultation
- HIV Section Medication Formulary Workgroup (HSMFW)
- Undetectable = Untransmittable (U=U)
- CDC HIV Basics (opens in a new window)
- CDC HIV Guidelines and Recommendations (opens in a new window)
- National HIV Curriculum for Clinicians (opens in a new window)
- Ryan White/Patient Care Programs
- U.S. Department of Health and Human Services HIV Treatment Guidelines (opens in a new window)
- HRSA Ryan White HIV/AIDS Program Medical Provider Finder (opens in a new window)
- HIV RNA testing (PDF, 291 KB, opens in a new window)
- Implementation Resources for Cabenuva, Revised May 2023 (PDF, 190 KB, opens in a new window)
- Provider Capacity Survey Results for Long-Acting Injectables (PDF, 324 KB, opens in a new window)
- Sunlenca Initiation Guide (PDF, 1,405 KB, opens in a new window)
- Lenacapavir Prior Authorization Form (PDF, 204 KB, opens in a new window)
- Non-Occupational Post Exposure Prophylaxis (nPEP) Guidance, Revised December 2020 (PDF, 364 KB, opens in a new window)
- Pre-Exposure Prophylaxis (PrEP) Clinical Guidance, Revised July 2022 (PDF, 870 KB, opens in a new window)
- Test & Treat Clinical Guidance, Revised October 2023 (PDF, 344 KB, opens in a new window)
- AIDS Drug Assistance Program (ADAP) Formulary (PDF, 491 KB, opens in a new window)
- AIDS Pharmaceutical Assistance (APA) Formulary (PDF, 155 KB, opens in a new window)
- BabyRxpress Program (PDF, 77 KB, opens in a new window)
- Pre-Exposure Prophylaxis (PrEP) Formulary (PDF, 109 KB, opens in a new window)
- Test and Treat (T&T) Formulary (PDF, 60 KB, opens in a new window)
- Formulary Change Request (PDF, 50 KB, opens in a new window)
- ADAP Semaglutide for Weight Loss Prior Authorization Form (PDF, 183 KB, opens in a new window)
- The Antiretroviral Pregnancy Registry (APR; link opens in a new window) is an epidemiologic project to collect observational, non-experimental data on antiretroviral (ARV) drug exposure during pregnancy for the purpose of assessing the potential teratogenicity of these drugs.
- NASTAD Pharmaceutical Company Patient Assistance Programs and Cost-sharing Assistance Programs: HIV Treatment (PDF, 203 KB, opens in a new window)
- NASTAD Pharmaceutical Company Patient Assistance Programs and Cost-sharing Assistance Programs: Hepatitis (PDF, 196 KB, opens in a new window)
- Pharmacertical samples contact sheet (PDF, 149 KB, opens in a new window; for clinicians and staff only)
- Regimen selection assistance available through HIV Assist (opens in a new window)
- For concerns about HIV drug interactions with other medications: HIV Drug Interaction Checker (opens in a new window) and Hepatitis Drug Interaction Checker (opens in a new window)
- For calculation of renal function and other medical calculators: Clinical Calculators (opens in a new window)
- For genotype/phenotype resistance reference: Stanford University Database (opens in a new window)
- For PrEP and nPEP information: PrEP and nPEP materials
- For the Ready, Set, PrEP national program: Health and Human Services (opens in a new window)
- For housing, medication or medical care for people with HIV: Ryan White/Patient Care Programs
- Perinatal HIV/AIDS: 1-888-448-8765
- Post-Exposure Prophylaxis: 1-888-448-4911
- General Clinical Questions: 1-800-933-3413
- Prenatal HIV: 1-800-451-BABY (2229)
- Additional Treatment Guidance: HIV Care Consultation at No Cost (opens in a new window)
Connect with DOH